Metagenomi Therapeutics MGX
NASDAQ MGX
$1.10 -0.03 (-3.11%)
As of: Sep 30, 2026 · 1:32 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Operating Leases (2023 - 2026)

Updated

Metagenomi Therapeutics (MGX) recorded Operating Leases of $31.49 million in Q2 2026, down 16.0% from $37.48 million a year earlier and down 4.8% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Operating Leases (2023 - 2026) Analysis & Trends

At the end of FY2025, Metagenomi Therapeutics reported Operating Leases of $34.63 million, down 13.8% from FY2024.

  • Across earlier years, Operating Leases came in at $40.19 million in FY2024 (-10.3%) and $44.8 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Operating Leases in data going back to Q4 2023.
  • On a year-over-year basis, Operating Leases has declined for seven consecutive quarters, with an average decline of 13.0% over the last seven quarters.
  • Per Business Quant, the preceding three quarters came in at $33.08 million (Q1 2026), $34.63 million (Q4 2025) and $36.09 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.49 Mn
Mar 31, 2026 33.08 Mn
Dec 31, 2025 34.63 Mn
Sep 30, 2025 36.09 Mn
Jun 30, 2025 37.48 Mn
Mar 31, 2025 38.83 Mn
Dec 31, 2024 40.19 Mn
Sep 30, 2024 41.38 Mn
Jun 30, 2024 42.55 Mn
Mar 31, 2024 43.68 Mn
Dec 31, 2023 44.80 Mn
API Access

Metagenomi Therapeutics, Inc. Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=MGX&period=max&api_key=YOUR_API_KEY